Filing Flows › Mimedx Group (MDXG) › Surgical revenue
Mimedx Group (MDXG) Surgical revenue by quarter
Mimedx Group's Surgical revenue was $40.0M in Q3 2026 (third quarter 2026), +2% from Q2 2026. Over the last 7 quarters it ranged from $32.1M (Q1 2025) to $40.0M (Q3 2026).
| Quarter | Surgical revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $40.0M | +2% | +9% |
| Q2 2026 | $39.3M | +8% | +15% |
| Q1 2026 | $36.4M | -8% | +13% |
| Q4 2025 | $39.4M | +8% | — |
| Q3 2025 | $36.6M | +7% | — |
| Q2 2025 | $34.1M | +6% | — |
| Q1 2025 | $32.1M | — | — |
Q3 2026 at a glance
Mimedx Group, Q3 2026: revenue $62.3M (-45% year over year), operating margin -18.8%, net loss $8.7M, operating cash flow $3.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is Mimedx Group's Surgical revenue?
Mimedx Group's Surgical revenue was $40.0M in Q3 2026 (third quarter 2026), +2% from Q2 2026.
How has Mimedx Group's Surgical revenue changed?
Over the last 7 quarters it ranged from $32.1M (Q1 2025) to $40.0M (Q3 2026).